ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
원숭이두창 검사 시장 규모는 향후 몇 년 동안 안정적으로 성장할 것으로 예상됩니다. 2029년에는 CAGR 4.4%로 18억 1,000만 달러로 성장할 것입니다. 예측 기간의 성장은 의료비 증가, 현장 진료(POC) 검사 개발, 가정용 검사 키트의 성장, 접근성 및 경제성에 대한 관심, 의료 인프라 개선 등에 기인합니다. 예측 기간의 주요 동향으로는 감시 시스템과의 통합, 디지털 헬스 툴과의 통합, 기술 발전, 공중 보건 시스템과의 통합, 진단 연구 발전 등을 들 수 있습니다.
향후 5년간 성장률 4.4%라는 예측은 지난번 예측보다 0.1% 소폭 하락한 수치입니다. 이 감소는 주로 미국과 다른 국가 간의 관세의 영향에 기인합니다. 관세 부과는 한국과 스위스에서 수입되는 중합효소 연쇄 반응(PCR) 검사 키트와 바이러스 수송 배지 비용을 상승시키고, 진단 시간을 지연시키거나 공중보건 검사 비용을 상승시킬 수 있기 때문에 미국의 발병 대응에 혼란을 초래할 수 있습니다. 또한, 상호 관세와 무역 긴장과 제한의 증가로 인한 세계 경제와 무역에 대한 악영향으로 인해 그 영향은 더욱 광범위하게 나타날 것으로 보입니다.
원숭이두창 발병률의 증가는 향후 원숭이두창 검사 시장의 성장을 촉진할 것으로 예상됩니다. 원숭이두창은 천연두 바이러스와 친척관계에 있는 오르토팍스 바이러스 속에 속하는 원숭이두 바이러스에 의해 발생하는 희귀한 바이러스성 질환입니다. 원숭이두창 환자 증가는 사람 간 감염 증가, 전 세계 여행, 천연두 백신 접종 프로그램 중단으로 인한 면역력 저하가 원인으로 꼽히고 있습니다. 원숭이두창 검사는 감염자 조기 발견, 적시 치료 및 격리를 통한 감염 확산 방지, 발생 상황 추적 및 감염 패턴 파악 등 중요한 역할을 하고 있습니다. 예를 들어, 2022년 5월 스웨덴에 본부를 둔 정부 기관인 유럽질병예방통제센터(ECDC)는 14개 주 54개 보건 지역에서 2022년 1월부터 4월까지 1,152건의 원숭이두창 의심 사례가 보고되었고, 55명이 사망했으며, 치사율은 4.8%였다고 밝혔습니다. 이는 2021년 같은 기간에 비해 의심환자가 138건, 사망자가 14건 증가하여 치사율이 10.1%로 높아졌다는 것을 보여줍니다. 그 결과, 원숭이두창 발생률의 증가가 원숭이두창 검사 시장의 확대를 주도하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역 전쟁과 관세, 그리고 코로나와 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 원숭이두창 검사 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업 분석
세계의 원숭이두창 검사 시장 : 성장률 분석
세계의 원숭이두창 검사 시장 실적 : 규모와 성장, 2019-2024
세계의 원숭이두창 검사 시장 예측 : 규모와 성장, 2024-2029, 2034F
세계의 원숭이두창 검사 : 총 잠재 시장 규모(TAM)
제6장 시장 세분화
세계의 원숭이두창 검사 시장 : 기술별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
중합효소 연쇄 반응(PCR)
측방유동분석법(LFA)
기타 기술
세계의 원숭이두창 검사 시장 모드별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
임상 검사
POC(Point of Care) 검사
세계의 원숭이두창 검사 시장 : 최종 용도별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
병원과 진료소
진단 검사실
기타 용도
세계의 원숭이두창 검사 시장 : 하위 세분화 중합효소 연쇄 반응(PCR), 종류별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
실시간 PCR(qPCR)
역전사 PCR(RT-PCR)
멀티플렉스 PCR
세계의 원숭이두창 검사 시장 : 하위 세분화 측방유동분석법(LFA), 유형별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
면역 크로마토그래피 측방유동분석법
신속 항원 검출 키트
세계의 원숭이두창 검사 시장 : 하위 세분화 기타 기술(종류별), 실적과 예측, 2019-2024, 2024-2029F, 2034F
ELISA(효소면역측정법)
CRISPR 기반 테스트
혈청학적 검사(항체 검출)
핵산 배열에 기반한 증폭(NASBA)
제7장 지역별·국가별 분석
세계의 원숭이두창 검사 시장 : 지역별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
세계의 원숭이두창 검사 시장 : 국가별, 실적과 예측, 2019-2024, 2024-2029F, 2034F
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 개요
원숭이두창 검사 시장 : 경쟁 구도
원숭이두창 검사 시장 : 기업 개요
F. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
Becton Dickinson and Company Overview, Products and Services, Strategy and Financial Analysis
Mayo Clinic Laboratories Overview, Products and Services, Strategy and Financial Analysis
제31장 기타 주요 기업과 혁신적 기업
Laboratory Corporation of America Holdings
Quest Diagnostics Incorporated
Sonic Healthcare Limited
bioMerieux S.A.
Bio-Rad Laboratories Inc.
QIAGEN N.V.
Cepheid Inc.
Aegis Sciences Corporation
Chembio Diagnostics Inc.
Flow Health Inc.
SeraCare Life Sciences Inc.
BioGX Inc.
Applied DNA Sciences Inc.
CerTest Biotec S.L.
Altona Diagnostics GmbH
제32장 세계의 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병
제34장 최근의 시장 동향
제35장 시장 잠재력이 높은 국가, 부문, 전략
원숭이두창 검사 시장 2029 : 새로운 기회를 제공하는 국가
원숭이두창 검사 시장 2029 : 새로운 기회를 제공하는 부문
원숭이두창 검사 시장 2029 : 성장 전략
시장 동향에 기반한 전략
경쟁 전략
제36장 부록
KSM
영문 목차
영문목차
Monkeypox testing refers to the diagnostic process used to detect the presence of the monkeypox virus in an individual. This testing is crucial for identifying and confirming cases of monkeypox, a viral zoonotic disease that can be transmitted from animals to humans and between humans.
The main technologies for money pox testing are polymerase chain reaction (PCR), lateral flow assay (LFA), and others. Polymerase Chain Reaction (PCR) is a molecular technique used to amplify and detect the DNA of the monkeypox virus in patient samples, making it a key tool for accurate and early diagnosis of the disease. It enables rapid identification of viral genetic material, crucial for controlling outbreaks. Testing modes include laboratory testing and point-of-care testing, with end users such as hospitals and clinics, diagnostic laboratories, and others.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The money pox testing market research report is one of a series of new reports from The Business Research Company that provides money pox testing market statistics, including the money pox testing industry's global market size, regional shares, competitors with a money pox testing market share, detailed money pox testing market segments, market trends and opportunities, and any further data you may need to thrive in the money pox testing industry. This money pox testing market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The monkey pox testing market size has grown steadily in recent years. It will grow from $1.46 billion in 2024 to $1.52 billion in 2025 at a compound annual growth rate (CAGR) of 4.5%. The growth in the historic period can be attributed to increasing government funding and initiatives, increasing demand to provide rapid tests, increasing testing capacity, increasing research and development, and increasing public awareness campaigns.
The monkey pox testing market size is expected to see steady growth in the next few years. It will grow to $1.81 billion in 2029 at a compound annual growth rate (CAGR) of 4.4%. The growth in the forecast period can be attributed to rising healthcare expenditures, development of point-of-care (POC) tests, growth in at-home testing kits, focus on accessibility and affordability, and healthcare infrastructure improvement. Major trends in the forecast period include integration of testing with surveillance systems, integration with digital health tools, technological advancements, integration into public health systems and advancements in diagnostic research.
The forecast of 4.4% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may disrupt U.S. outbreak response by increasing costs for Polymerase Chain Reaction(PCR) test kits and viral transport media imported from South Korea and Switzerland, potentially slowing diagnostic turnaround times and raising public health laboratory expenses. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The rising incidence of monkeypox is expected to drive growth in the monkeypox testing market moving forward. Monkeypox is a rare viral disease caused by the monkeypox virus, which belongs to the orthopoxvirus genus, closely related to the smallpox virus. The increase in monkeypox cases is attributed to heightened human-to-human transmission, global travel, and decreased immunity due to the cessation of smallpox vaccination programs. Monkeypox testing plays a crucial role by enabling early identification of infected individuals, facilitating timely treatment and isolation to curb further spread, and aiding in tracking outbreaks and understanding transmission patterns. For example, in May 2022, the European Centre for Disease Prevention and Control (ECDC), a Sweden-based government agency, reported 1,152 suspected monkeypox cases from January to April 2022, resulting in 55 deaths and a case-fatality rate of 4.8%, across 54 health zones in 14 provinces. This represents an increase of 138 suspected cases and 14 deaths compared to the same period in 2021, leading to a higher case-fatality rate of 10.1%. Consequently, the growing incidence of monkeypox is driving the expansion of the monkeypox testing market.
Major companies in the monkeypox testing market are focusing on developing advanced diagnostic solutions, such as saliva-based monkeypox tests, to improve accuracy, convenience, and accessibility. Saliva-based monkeypox testing is a method that detects the monkeypox virus using saliva samples. For example, in July 2022, Flow Health, a US-based medical laboratory, introduced a saliva-based PCR test for monkeypox. This innovative test offers a more convenient and non-invasive method for virus detection, featuring high sensitivity and specificity, rapid genetic material amplification, and adaptability for various uses. It enables quantitative analysis of viral loads and direct pathogen detection while simplifying sample collection. A significant advantage of this test is its ability to detect the virus before visible lesions appear, which is crucial for early detection and reducing the spread of the virus.
In September 2023, BioNTech, a UK-based biotechnology firm, entered into a partnership with the Coalition for Epidemic Preparedness Innovations (CEPI) for an undisclosed amount. This collaboration aims to accelerate the development of effective vaccines for mpox (formerly known as monkeypox), a disease that has gained significant attention due to recent outbreaks. The Coalition for Epidemic Preparedness Innovations (CEPI) is a UK-based public-private entity dedicated to advancing vaccine development.
Major companies operating in the monkey pox testing market are F. Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson and Company, Mayo Clinic Laboratories, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Sonic Healthcare Limited, bioMerieux S.A., Bio-Rad Laboratories Inc., QIAGEN N.V., Cepheid Inc., Aegis Sciences Corporation, Chembio Diagnostics Inc., Flow Health Inc., SeraCare Life Sciences Inc., BioGX Inc., Applied DNA Sciences Inc., CerTest Biotec S.L., Altona Diagnostics GmbH, Creative Biogene Inc., ACON Biotech (Hangzhou) Co Ltd.
North America was the largest region in the monkey pox testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the monkey pox testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the monkey pox testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The monkey pox testing market consist of revenues earned by entities by providing services such as laboratory testing, diagnostic consultation, sample collection, result reporting, contact tracing, and follow-up. The market value includes the value of related goods sold by the service provider or included within the service offering. The monkey pox testing market also includes of sales of serological testing equipment, centrifuges, refrigeration units, biosafety cabinets, automated nucleic acid extractors, and microscopes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Monkey Pox Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on monkey pox testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for monkey pox testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The monkey pox testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Technology: Polymerase Chain Reaction (PCR); Lateral Flow Assay (LFA); Other Technologies
2) By Mode: Laboratory Testing; Point Of Care Testing
3) By End-Use: Hospitals And Clinics; Diagnostic Laboratories; Other End-Uses
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Monkey Pox Testing Market Characteristics
3. Monkey Pox Testing Market Trends And Strategies
4. Monkey Pox Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Monkey Pox Testing Growth Analysis And Strategic Analysis Framework
5.1. Global Monkey Pox Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Monkey Pox Testing Market Growth Rate Analysis
5.4. Global Monkey Pox Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Monkey Pox Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Monkey Pox Testing Total Addressable Market (TAM)
6. Monkey Pox Testing Market Segmentation
6.1. Global Monkey Pox Testing Market, Segmentation By Technology, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Polymerase Chain Reaction (PCR)
Lateral Flow Assay (LFA)
Other Technologies
6.2. Global Monkey Pox Testing Market, Segmentation By Mode, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Laboratory Testing
Point Of Care Testing
6.3. Global Monkey Pox Testing Market, Segmentation By End-Use, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Diagnostic Laboratories
Other End-Uses
6.4. Global Monkey Pox Testing Market, Sub-Segmentation Of Polymerase Chain Reaction (PCR), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Real-Time PCR (qPCR)
Reverse Transcription PCR (RT-PCR)
Multiplex PCR
6.5. Global Monkey Pox Testing Market, Sub-Segmentation Of Lateral Flow Assay (LFA), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Immunochromatographic Lateral Flow Assays
Rapid Antigen Detection Kits
6.6. Global Monkey Pox Testing Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
ELISA (Enzyme-Linked Immunosorbent Assay)
CRISPR-based Testing
Serological Tests (Antibody Detection)
Nucleic Acid Sequence-Based Amplification (NASBA)
7. Monkey Pox Testing Market Regional And Country Analysis
7.1. Global Monkey Pox Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Monkey Pox Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
